Cel-Sci
CVM
#9791
Rank
โ‚ฌ41.14 M
Marketcap
4,89ย โ‚ฌ
Share price
-1.19%
Change (1 day)
-57.14%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ10.29 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are โ‚ฌ10.29 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30โ‚ฌ10.39 M-18.05%
2024-09-30โ‚ฌ12.68 M-22.45%
2023-09-30โ‚ฌ16.35 M-12.85%
2022-09-30โ‚ฌ18.76 M12.33%
2021-09-30โ‚ฌ16.7 M-5.87%
2020-09-30โ‚ฌ17.74 M-13.99%
2019-09-30โ‚ฌ20.63 M-19.06%
2018-09-30โ‚ฌ25.49 M13.98%
2017-09-30โ‚ฌ22.36 M-1.94%
2016-09-30โ‚ฌ22.8 M-23.51%
2015-09-30โ‚ฌ29.82 M328.57%
2014-09-30โ‚ฌ6.95 M127.4%
2013-09-30โ‚ฌ3.05 M-56.64%
2012-09-30โ‚ฌ7.05 M0.33%
2011-09-30โ‚ฌ7.03 M-3.7%
2010-09-30โ‚ฌ7.3 M-71.49%
2009-09-30โ‚ฌ25.61 M833.22%
2008-09-30โ‚ฌ2.74 M-35.52%
2007-09-30โ‚ฌ4.25 M-49.07%
2006-09-30โ‚ฌ8.35 M917.54%
2005-09-30โ‚ฌ0.82 M-26.7%
2004-09-30โ‚ฌ1.12 M-22.89%
2003-09-30โ‚ฌ1.45 M-47.34%
2002-09-30โ‚ฌ2.76 M394.78%
2001-09-30โ‚ฌ0.55 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ95.78 B 930,646.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ67.92 B 659,986.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.20 B 1,896.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ35.71 M 247.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.50 B 267,157.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.70 B 6,739.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.74 B 7,101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ2.19 M-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA